Ilan Ganot - 27 Jan 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director
Issuer ticker: SLDB
Reported as of: 27 Jan 2026
Net transaction value: -$1,259
SEC form: 4
Accepted by SEC: 30 Jan 2026, 16:05:07 UTC
Prior SEC filing: 06 Jan 2026
Next SEC filing: 06 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot

Key filing fact

Ilan Ganot filed Form 4 for Solid Biosciences Inc. (SLDB) on 30 Jan 2026.

Key facts

This page summarizes Ilan Ganot's Form 4 filing for Solid Biosciences Inc. (SLDB).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 30 Jan 2026, 16:05.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: -$1,259.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727460 Primary reporting owner

Ganot Ilan

Relationship: Director
Address: C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN
Signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot
Signature date: 29 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDB transaction

Common Stock

Options Exercise

Transaction value
Shares: +389
Change %: +2.3%
Price
Shares after: 17,667
Date: 27 Jan 2026
Ownership: Wife
Footnotes: F1

SLDB transaction

Common Stock

Sale

Transaction value: $1,259
Shares: -191
Change %: -1.1%
Price: $6.59
Shares after: 17,476
Date: 28 Jan 2026
Ownership: Wife
Footnotes: F2

SLDB transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,884
Change %: +4.1%
Price
Shares after: 99,297
Date: 27 Jan 2026
Ownership: Direct
Footnotes: F1, F3

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,394
Date: 27 Jan 2026
Ownership: See Footnote
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -389
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 27 Jan 2026
Ownership: Wife
Underlying class: Common Stock
Underlying amount: 389
Exercise price
Footnotes: F1, F5

SLDB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -3,884
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 27 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,884
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Footnote F3

Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Footnote F4

Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

Footnote F5

On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Footnote F6

On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.